16.07.2013 Views

Full Journal - Journal of Cell and Molecular Biology - Haliç Üniversitesi

Full Journal - Journal of Cell and Molecular Biology - Haliç Üniversitesi

Full Journal - Journal of Cell and Molecular Biology - Haliç Üniversitesi

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Figure 3: Several sources <strong>of</strong> PAs are available for rapidly<br />

growing cells in vivo. The endogenous sources arise from a<br />

highly regulated intracellular metabolism <strong>and</strong> the exogenous<br />

sources arise principally from the gastrontestinal (GI) tract.<br />

Intestinal <strong>and</strong> colonic mucosa absorb PA released from food<br />

<strong>and</strong> from micr<strong>of</strong>loral biosynthesis as well. PA<br />

originating from different source are finally transported by<br />

circulating blood, particullarly in red blood cells (RBC) in<br />

normal conditions or PA can be accumulated at situ under<br />

inflammatory conditions via migration <strong>of</strong> activated white<br />

blood cells (WBC). When needed, a membrane transport<br />

system allows the host cells to uptake PA from<br />

extracellular compartments.<br />

carrier-mediated (Seiler <strong>and</strong> Dezeure, 1990; Seiler et<br />

al., 1996; Aziz et al., 1994; Toursarkissian et al;<br />

1994). Although, not studied in most cell types, a<br />

human gene for polyamine transport has been<br />

expressed in polyamine deficient Chinese-hamster<br />

ovary (CHO) mutant cell line (Byers <strong>and</strong> Pegg, 1989;<br />

Hyvonen et al., 1994). Many cells posses single<br />

transmembrane carrier capable transporting Put, Spd<br />

<strong>and</strong> Spm. However, in one quarter <strong>of</strong> all cell types<br />

examined (reports from competition studies) suggests<br />

that more than one carrier (or in general terms, more<br />

than one transporter for polyamine uptake into the<br />

cells; one for Put only <strong>and</strong> one for Put, Spd <strong>and</strong> Spm)<br />

is present (Aziz et al., 1994; Toursarkissian et al;<br />

1994; Minchin et al., 1991). Different cells posses<br />

both saturable, <strong>and</strong> non-saturable uptake systems.<br />

Polyamine uptake by saturable systems is temperature<br />

dependent <strong>and</strong> carrier-mediated. The presence <strong>of</strong><br />

unsaturable components in the polyamine transport<br />

system in some cell types has been reported, but the<br />

evidence is based on the results <strong>of</strong> statistical non-linear<br />

regression analysis <strong>and</strong> computer-fitting <strong>of</strong> the data to<br />

the appropriate equations (Minchin et al., 1991).<br />

In general, the affinity <strong>of</strong> the transporter carrier<br />

increases from Put, Spd <strong>and</strong> Spm. In all cell types<br />

investigated PA transport is independent <strong>and</strong> distinct<br />

from amino acid transport systems <strong>and</strong> in some cells<br />

it appears to be sodium-dependent (Palacin et al.,<br />

1998). Although uptake is observed, in the absence <strong>of</strong><br />

Na + , the exogenously increase <strong>of</strong> sodium in the<br />

medium to physiological concentrations (120 mM)<br />

usually increase the transport rate by 60%.<br />

Modulation <strong>of</strong> the Na-dependent portion by<br />

ionophores (gramicidin or monensin) inhibits<br />

sodium-dependent portion <strong>of</strong> PA uptake (Khan et al.,<br />

1992). In addition, natural polyamines, Put, Spd,<br />

Spm, a large number <strong>of</strong> polyamine analogues can also<br />

be taken up by this system. This lack <strong>of</strong> specificity <strong>of</strong><br />

polyamine uptake systems in the cells have been<br />

made possible exploitation <strong>of</strong> polyamine-like drugs<br />

for use in cancer chemotheraphy or in other<br />

chemotherapeutic approaches to various diseases<br />

(Kramer et al., 1993).<br />

The structural tolerances <strong>of</strong> the PA transport<br />

systems allowed the selection <strong>of</strong> cells resistant to the<br />

cytotoxic action <strong>of</strong> MGBG, which after limited<br />

mutagenesis had lost their ability to take up PA from<br />

the environment. Uptake-deficient mutants have<br />

widely been used to characterize the uptake systems<br />

or non-specific uptakes used by analogs with<br />

structural relationships to PA. One example to these<br />

uptake-deficient mutant CHO cells is CHO-MGBG<br />

cells. Studies with CHO-MGBG cells also revealed<br />

that PA uptake <strong>and</strong> export mediated by different<br />

transport systems (Put release was observed in<br />

uptake-deficient CHO-MGBG cells) (Hyvonen et al.,<br />

1994). This may not necessarily imply that the<br />

transporter proteins for uptake <strong>and</strong> release are<br />

different. Uptake deficient mutants may not simply<br />

lack an active transporter protein, but another<br />

important constituent activating uptake part only<br />

(Seiler et al., 1996).<br />

ODC <strong>and</strong> proto-oncogenes<br />

Polyamines 63<br />

Various carcinogens, mitogen stimuli <strong>and</strong> tumor<br />

promoters may cause transient increases in ODC<br />

activity, while rapidly proliferating tissues, including<br />

tumors, activated macrophages <strong>and</strong> the cells <strong>of</strong> gut<br />

mucosa have constantly elevated ODC activities <strong>and</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!